Article
Successful treatment of psoriasis with secukinumab constructed a new homeostasis of gut microbiome
2022-07-21
Abstract excerpt
<h4>Background: </h4> Secukinumab (an interleukin (IL)-17 inhibitor) has been reported to be able to alter gut microbiome composition in psoriatic patients. However, it still remains unclear the gut microbiota alteration and related functional changes caused by successful secukinumab therapy in psoriatic patients. In this study, fecal samples from healthy people as comtrol (H; n=35), psoriatic patients without the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8c55efb3-16f1-59fb-afe5-b856de32b5fe
- DOI
- 10.21203/rs.3.rs-1871031/v1
